Hologic, Inc. (HOLX) Given “Sector Perform” Rating at Royal Bank Of Canada

Royal Bank Of Canada restated their sector perform rating on shares of Hologic, Inc. (NASDAQ:HOLX) in a research note released on Wednesday. The brokerage currently has a $45.00 target price on the medical equipment provider’s stock, down from their prior target price of $50.00.

A number of other research analysts also recently weighed in on HOLX. Deutsche Bank AG cut their price target on shares of Hologic from $51.00 to $49.00 and set a buy rating on the stock in a report on Thursday, August 3rd. Jefferies Group LLC set a $49.00 price target on shares of Hologic and gave the company a buy rating in a report on Sunday, May 28th. BidaskClub downgraded shares of Hologic from a buy rating to a hold rating in a report on Wednesday, August 2nd. Needham & Company LLC restated a buy rating on shares of Hologic in a report on Tuesday, August 1st. Finally, Zacks Investment Research upgraded shares of Hologic from a sell rating to a hold rating in a report on Friday, August 4th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the stock. Hologic currently has an average rating of Buy and an average target price of $48.64.

Shares of Hologic (HOLX) opened at 38.20 on Wednesday. The stock has a market capitalization of $10.71 billion, a PE ratio of 14.23 and a beta of 0.90. The company’s 50-day moving average is $43.73 and its 200-day moving average is $42.89. Hologic has a 12 month low of $35.15 and a 12 month high of $46.80.

Hologic (NASDAQ:HOLX) last released its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.50 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.01. The business had revenue of $806.10 million for the quarter, compared to the consensus estimate of $799.70 million. Hologic had a net margin of 25.65% and a return on equity of 23.18%. Hologic’s revenue for the quarter was up 12.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.51 EPS. Equities research analysts expect that Hologic will post $2.01 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Hologic, Inc. (HOLX) Given “Sector Perform” Rating at Royal Bank Of Canada” was posted by Transcript Daily and is the property of of Transcript Daily. If you are accessing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this news story can be accessed at https://transcriptdaily.com/2017/08/13/hologic-inc-holx-given-sector-perform-rating-at-royal-bank-of-canada.html.

In other news, Director Lawrence M. Levy sold 2,960 shares of Hologic stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $44.54, for a total transaction of $131,838.40. Following the sale, the director now directly owns 45,634 shares in the company, valued at approximately $2,032,538.36. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Lawrence M. Levy sold 9,076 shares of Hologic stock in a transaction dated Wednesday, May 17th. The shares were sold at an average price of $42.80, for a total transaction of $388,452.80. Following the sale, the director now owns 43,165 shares in the company, valued at $1,847,462. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 60,627 shares of company stock worth $2,632,911. 0.79% of the stock is owned by company insiders.

A number of institutional investors have recently added to or reduced their stakes in HOLX. Teachers Advisors LLC raised its position in Hologic by 28.8% in the fourth quarter. Teachers Advisors LLC now owns 643,547 shares of the medical equipment provider’s stock worth $25,819,000 after buying an additional 143,960 shares during the period. Chevy Chase Trust Holdings Inc. raised its position in Hologic by 3.6% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 240,769 shares of the medical equipment provider’s stock worth $10,245,000 after buying an additional 8,289 shares during the period. Gulf International Bank UK Ltd raised its position in Hologic by 1.5% in the first quarter. Gulf International Bank UK Ltd now owns 74,164 shares of the medical equipment provider’s stock worth $3,155,000 after buying an additional 1,100 shares during the period. National Pension Service raised its position in Hologic by 55,168.1% in the first quarter. National Pension Service now owns 244,285 shares of the medical equipment provider’s stock worth $10,433,000 after buying an additional 243,843 shares during the period. Finally, Bank of Montreal Can raised its position in Hologic by 67.8% in the first quarter. Bank of Montreal Can now owns 3,206,769 shares of the medical equipment provider’s stock worth $136,448,000 after buying an additional 1,295,885 shares during the period. Hedge funds and other institutional investors own 94.46% of the company’s stock.

About Hologic

Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.

Analyst Recommendations for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply